Neuropilin-2: Novel Biomarker and Therapeutic Target for Aggressive Prostate Cancer

doi 10.21236/ada611823
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

Journal of Oncology
Oncology
2018English

Soluble Endoglin (sCD105) as a Novel Biomarker for Detecting Aggressive Prostate Cancer

Anticancer Research
MedicineCancer ResearchOncology
2020English

DDX49 Is a Novel Biomarker and Therapeutic Target for Lung Cancer Metastases

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2020English

Neuropilin-1 as Therapeutic Target for Malignant Melanoma

Frontiers in Oncology
Cancer ResearchOncology
2015English

HMGB1: A Promising Therapeutic Target for Prostate Cancer

Prostate Cancer
Cancer ResearchOncologyUrology
2013English

EP4 as a Therapeutic Target for Aggressive Human Breast Cancer

2018English

Transgelin in Bladder Cancer: A Potential Biomarker and Therapeutic Target

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Recent Developments in Prostate Cancer Biomarker Research: Therapeutic Implications

British Journal of Clinical Pharmacology
Pharmacology
2010English

Pirin: A Potential Novel Therapeutic Target for Castration-Resistant Prostate Cancer Regulated by miR-455-5p

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy